ConductScience.org, home

Paper42588134

Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A.

Rzeski W and 1 other. Nutrients, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A. Papers, record 42588134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42588134

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A.
PubMed
Journal
Nutrients
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rzeski WWojciechhttps://orcid.org/0000-0002-4511-1498
2Rzeska WWeronikahttps://orcid.org/0000-0003-1238-9132

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CoumarinsMajor topic
AgingMajor topic
SpermidineMajor topic
BerberineMajor topic
Functional FoodMajor topic
FlavonoidsMajor topic
Humans
Flavonols
Animals
Autophagy

Source PubMed

Download CSV of topics

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139384074Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases.Mech Ageing Dev2024https://conductscience.org/library/papers/39384074PubMed
234535644A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes.Nat Commun2021https://conductscience.org/library/papers/34535644PubMed
332694802The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans.Nat Metab2019https://conductscience.org/library/papers/32694802PubMed
424527031Cyclosporine and herbal supplement interactions.J Toxicol2014https://conductscience.org/library/papers/24527031PubMed
529371440Spermidine in health and disease.Science2018https://conductscience.org/library/papers/29371440PubMed
627400265Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents.Nat Med2016https://conductscience.org/library/papers/27400265PubMed
731358955Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe.Eur J Hum Genet2020https://conductscience.org/library/papers/31358955PubMed
827112200Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors.Sci Rep2016https://conductscience.org/library/papers/27112200PubMed
941690118The autophagy-senescence axis as a threshold model of aging and therapeutic targeting.Redox Biol2026https://conductscience.org/library/papers/41690118PubMed
1036057633Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression.Nat Commun2022https://conductscience.org/library/papers/36057633PubMed
1123746838The hallmarks of aging.Cell2013https://conductscience.org/library/papers/23746838PubMed
1241168834POLYamine treatment in elderly patients with Coronary Artery Disease (POLYCAD): study protocol for a Danish randomised, double-blind, placebo-controlled trial of spermidine treatment versus placebo.Trials2025https://conductscience.org/library/papers/41168834PubMed
1322048312Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.Nature2011https://conductscience.org/library/papers/22048312PubMed
1440437670
Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging: A Comparison to Genetic Clearance of Senescent Cells and Synthetic Senolytic Approaches.
Aging Cell2025https://conductscience.org/library/papers/40437670PubMed
1529315079Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline.Aging (Albany NY)2018https://conductscience.org/library/papers/29315079PubMed
1636599349Hallmarks of aging: An expanding universe.Cell2023https://conductscience.org/library/papers/36599349PubMed
1736840624Gut Bacteria Involved in Ellagic Acid Metabolism To Yield Human Urolithin Metabotypes Revealed.J Agric Food Chem2023https://conductscience.org/library/papers/36840624PubMed
1825526088Spermidine induces autophagy by inhibiting the acetyltransferase EP300.Cell Death Differ2015https://conductscience.org/library/papers/25526088PubMed
1935050355Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial.JAMA Netw Open2022https://conductscience.org/library/papers/35050355PubMed
2031905019Functional Foods: Product Development, Technological Trends, Efficacy Testing, and Safety.Annu Rev Food Sci Technol2020https://conductscience.org/library/papers/31905019PubMed

See all 77 referencesDownload CSV of references

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42588134

GET https://conductscience.org/api/papers/v1/42588134/references?page=2